Generic Entry for Small-Molecule Drugs Under Hatch-Waxman Act Topic of White Paper From CRS
June 18, 2025
June 18, 2025
WASHINGTON, June 18 (TNSLrpt) -- The Congressional Research Service issued the following In Focus white paper (No. IF13028) on June 12, 2025, by legislative attorney Kevin J. Hickey.
Here are excerpts:
* * *
Pharmaceutical Patent Disputes: Generic Entry for Small-Molecule Drugs Under the Hatch-Waxman Act
Patent rights play an important role in the development and pricing of pharmaceutical drugs. Patent law seeks to encourage innovation by grant . . .
Here are excerpts:
* * *
Pharmaceutical Patent Disputes: Generic Entry for Small-Molecule Drugs Under the Hatch-Waxman Act
Patent rights play an important role in the development and pricing of pharmaceutical drugs. Patent law seeks to encourage innovation by grant . . .